Study shows that anti-PTM antibodies are often present in autoimmune mediated liver disease

FHS
July 31, 2023
11:28 am

A recent study published in Frontiers in Medicine described anti-post-translational modification (PTM) antibodies in patients with autoimmune-mediated and cholestatic liver diseases (AILD).

How science journals are confronting the ‘existential’ question of politics this election

Donald Trump has changed the way scientists engage with presidential elections. After he was voted president in 2016, tens of thousands attended the March for

November 1, 2024

To get a fair deal on Wegovy, buying Novo Nordisk might not be Medicare’s worst option

Medicare and Medicaid are facing a familiar quandary: how to provide coverage for new weight loss drugs with price tags that could effectively bankrupt the

July 23, 2024

Hiring in global pharma industry drop 31% in Q3 2023

Notably, Management Occupations jobs accounted for a 19% share of the global pharma industry’s new job postings in Q3 2023, down 44% over the prior

October 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.